Literature DB >> 10471398

Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.

W N Chen1, C J Oon.   

Abstract

Mutations in the human hepatitis B virus (HBV) genome contribute to its escape from host immune surveillance and result in persistent infection. We report the identification of frequent mutations encompassing residues 29 to 53 of the HBV surface antigen in chronic HBV carriers as well as in patients with hepatocellular carcinoma. The location of these mutations, not found in patients with acute hepatitis and vaccinated infants, coincides with a human leukocyte antigen class I-restricted cytotoxic T lymphocyte epitope. Significantly, mutations occur at a higher frequency (83%) compared with those identified on the immunogenic "a" determinant (25%) of the corresponding patients. Our findings therefore suggest the potential importance of this novel mutation "hot spot" in the establishment of chronic HBV infection. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471398     DOI: 10.1006/bbrc.1999.1267

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies.

Authors:  María L Cuestas; Verónica L Mathet; Vanesa Ruiz; María L Minassian; Cintia Rivero; Andrea Sala; Daniel Corach; Analía Alessio; Marcia Pozzati; Bernardo Frider; José R Oubiña
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Full-length hepatitis B virus sequences from naïve patients with fluctuation of viral load during ADV monotherapy.

Authors:  Yongwei Li; Mingfen Zhu; Yunwei Guo; Wei Chen; Gang Li
Journal:  Virus Genes       Date:  2009-12-12       Impact factor: 2.332

3.  Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.

Authors:  Ye-Gui Jiang; Yu-Ming Wang; Tong-Hua Liu; Jun Liu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

4.  Curative effects of interferon-alpha and HLA-DRB1 -DQA1 and -DQB1 alleles in chronic viral hepatitis B.

Authors:  Guo-Qing Zang; Min Xi; Ming-Liang Feng; Yun Ji; Yong-Sheng Yu; Zheng-Hao Tang
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

5.  Hepatitis B virus S gene escape mutants.

Authors:  Michael A Purdy
Journal:  Asian J Transfus Sci       Date:  2007-07

6.  Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy.

Authors:  Maryam Daram; Ghodratollah Montazeri; Hadi Karimzadeh; Reza Malekzadeh; Mahmood Mahmoodi; Zahra Goodarzi; Hossein Keyvani; Shahram Mirmomen; Seyed Moayed Alavian; Michael Roggendorf; Seyed Mohammad Jazayeri
Journal:  Iran J Basic Med Sci       Date:  2014-09       Impact factor: 2.699

Review 7.  Clinical Relevance of HLA Gene Variants in HBV Infection.

Authors:  Li Wang; Zhi-Qiang Zou; Kai Wang
Journal:  J Immunol Res       Date:  2016-05-08       Impact factor: 4.818

8.  Association between the HLA-DQB1 polymorphisms and the susceptibility of chronic hepatitis B: A comprehensive meta-analysis.

Authors:  Jinmei Huang; Liangshi Xiong; Jin Wang; Yongfang Liu; Qirong Zhu; Jun Lei; Zhonghui Zhou
Journal:  Biomed Rep       Date:  2016-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.